================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ImmuCell Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.10 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
452525306
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2002
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
================================================================================
=================== =================
CUSIP No. 452525306 PAGE 2 OF 5 PAGES
=================== =================
================================================================================
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Joseph H. Crabb
------ ------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
------ ------------------------------------------------------------------------
3 SEC USE ONLY
------ ------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 178,769 (includes 122,769 shares subject to options
that are exercisable within 60 days)
SHARES ------ ------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY EACH ------ ------------------------------------------------------
7 SOLE DISPOSITIVE POWER
REPORTING
178,769 (includes 122,769 shares subject to options
PERSON that are exercisable within 60 days)
------ ------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
178,769 (includes 122,769 shares subject to options that are exercisable
within 60 days)
------ ------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions) [_]
------ ------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.3%
------ ------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
================================================================================
=================== =================
CUSIP No. 452525306 PAGE 3 OF 5 PAGES
=================== =================
Item 1(a). Name of Issuer:
--------------
ImmuCell Corporation
Item 1(b). Address of Issuer's Principal Executive Offices:
-----------------------------------------------
56 Evergreen Drive
Portland, ME 04103
Item 2(a). Name of Persons Filing:
----------------------
Joseph H. Crabb
Item 2(b). Address of Principal Business Office or, if None, Residence:
-----------------------------------------------------------
The business address of Joseph H. Crabb is c/o ImmuCell
Corporation, 56 Evergreen Drive, Portland, ME 04103.
Item 2(c). Citizenship.
-----------
Dr. Crabb is a citizen of the United States.
Item 2(d). Title of Class of Securities:
----------------------------
common stock, par value $0.10 per share ("Common Stock").
Item 2(e). CUSIP Number:
------------
452525306
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b)
-----------------------------------------------------------------
or (c), check whether the person filing is a:
--------------------------------------------
Not applicable.
Item 4. Ownership.
---------
(a) Amount Beneficially Owned:
-------------------------
Dr. Crabb beneficially owns 178,769 shares of Common Stock
of the Issuer, which includes 122,769 shares subject to
options that are exercisable within 60 days.
=================== =================
CUSIP No. 452525306 PAGE 4 OF 5 PAGES
=================== =================
(b) Percent of Class: 6.3%.
----------------
(c) Number of shares as to which such person has:
--------------------------------------------
(i) Sole power to vote or to direct the vote:
178,769 (includes 122,769 shares subject to options
that are exercisable within 60 days.)
(ii) Shared power to vote or to direct the vote: 0
(iii) Sole power to dispose or to direct the disposition of:
178,769 (includes 122,769 shares subject to options
that are exercisable within 60 days.)
(iv) Shared power to dispose or direct the disposition of:
0
Item 5. Ownership of Five Percent or Less of a Class.
--------------------------------------------
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following [_].
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
---------------------------------------------------------------
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
------------------------------------------------------------------
the Security Being Reported on by the Parent Holding Company or
---------------------------------------------------------------
Control Person.
--------------
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
---------------------------------------------------------
Not Applicable.
=================== =================
CUSIP No. 452525306 PAGE 5 OF 5 PAGES
=================== =================
Item 9. Notice of Dissolution of Group.
------------------------------
Not Applicable.
Item 10. Certifications.
--------------
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: January 9, 2003 /s/ Joseph H. Crabb
---------------------
Joseph H. Crabb